-
1541
The prognostic and immunomodulatory role of the MMR system in patients with stomach adenocarcinoma
Published 2025-01-01“…The clinical value of the MMR molecular marker as an immunotherapy for advanced solid tumors has been documented. …”
Get full text
Article -
1542
MicroRNA-150-3p enhances the antitumour effects of CGP57380 and is associated with a favourable prognosis in non-small cell lung cancer
Published 2025-01-01“…High miR-150-3p expression may enhance the response to immunotherapy, cisplatin and gemcitabine. In summary, this study underscores the promising therapeutic implications of combining miR-150-3p and CGP57380 for NSCLC treatment. …”
Get full text
Article -
1543
High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma
Published 2023-01-01“…High and low TET1 expression groups had distinct immune cell infiltration and response to immunotherapy and chemotherapy. We identified 90 DEGs related to DNA demethylation in high vs. low TET1 expression groups. …”
Get full text
Article -
1544
DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
Published 2025-02-01“…The integration of epigenetic therapies and immunotherapy offers a promising avenue for improving survival in TNBC patients.…”
Get full text
Article -
1545
Evaluation of Epstein-Barr Virus Latent Membrane Protein 2 Specific T-Cell Receptors Driven by T-Cell Specific Promoters Using Lentiviral Vector
Published 2011-01-01“…Transduction of latent membrane protein 2 (LMP2)-specific T-cell receptors into activated T lymphocytes may provide a universal, MHC-restricted mean to treat EBV-associated tumors in adoptive immunotherapy. We compared TCR-specific promoters of distinct origin in lentiviral vectors, that is, Vβ6.7, delta, luria, and Vβ5.1 to evaluate TCR gene expression in human primary peripheral blood monocytes and T cell line HSB2. …”
Get full text
Article -
1546
Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
Published 2025-01-01“…Tafasitamab, a CD19-targeting immunotherapy, combined with lenalidomide, is approved for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) treatment in adults ineligible for autologous stem cell transplantation. …”
Get full text
Article -
1547
Perturbations in gut microbiota composition in patients with autoimmune neurological diseases: a systematic review and meta-analysis
Published 2025-02-01“…Subgroup analyses assessed the confounding effects of geography and immunotherapy use. These findings suggest that disturbances of the gut flora are associated with autoimmune neurological diseases, primarily manifesting as non-specific and shared microbial alterations, including a reduction in SCFA-producing bacteria and an increase in pathogenic or opportunistic pathogens.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42023410215.…”
Get full text
Article -
1548
LINC01355 Contributes to Malignant Phenotype of Oral Squamous Cell Carcinoma and Cytotoxic T Cell Infiltration via Activating Notch Signaling Pathway
Published 2021-01-01“…Knockdown of LINC01355 repressed OSCC cell proliferation, migration, and invasion. Recently, immunotherapy is a significant method for the treatment of cancers, in which CD8+ T cells exhibit a significant role. …”
Get full text
Article -
1549
-
1550
Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
Published 2025-01-01“…Immune dysfunction is one of the hallmarks of cancer and plays critical roles in immunotherapy resistance, but there is no serum biomarker that can be used to evaluate immune-dysfunction status of cancer patients. …”
Get full text
Article -
1551
Next-generation sequencing and immuno-informatics for designing a multi-epitope vaccine against HSV-1-induced uveitis
Published 2025-01-01“…Molecular docking simulations showed strong binding interactions between the vaccine and TLR-9, suggesting enhanced antigen presentation capabilities.ConclusionThis comprehensive immuno-informatics approach provides a precision immunotherapy strategy for uveitis by leveraging computational modeling and predictive analytics to design a multi-epitope vaccine for HSV-1. …”
Get full text
Article -
1552
Different immunological characteristics of asymptomatic and symptomatic COVID-19 patients without vaccination in the acute and convalescence stages
Published 2025-01-01“…These findings may provide new insights into COVID-19 immunotherapy and immune intervention.…”
Get full text
Article -
1553
LAMB1 promotes proliferation and metastasis in nasopharyngeal carcinoma and shapes the immune-suppressive tumor microenvironment
Published 2025-03-01“…Tumors with high LAMB1 level had weak responses to immunotherapy. In vitro experiment, LAMB1 significantly suppressed HLA-1 and enhanced the proliferation, migration, and invasion capabilities of NPC cells. …”
Get full text
Article -
1554
Case Report: The Versatile Art of Reconstruction: A Decade‐Long Journey With Recurrent Facial Basal Cell Carcinoma
Published 2025-01-01“…Although no chemotherapy and immunotherapy were given, the functional and aesthetic result were satisfactory. …”
Get full text
Article -
1555
Circulating CD3+HLA-DR+ Extracellular Vesicles as a Marker for Th1/Tc1-Type Immune Responses
Published 2019-01-01“…The results suggest that these EV subpopulations reflect in vivo activation status of total CD4+, total CD8+, and Th1/Tc1-type T cells, respectively, and may be helpful in T cell-related clinical settings, such as cancer immunotherapy and treatment of chronic infection, autoimmune diseases, and graft-versus-host disease.…”
Get full text
Article -
1556
Research Progress of Crustacean Allergens and Allergens Specific Immunological Products
Published 2025-01-01“…It also summarizes the antigen epitope of allergens and discusses the immunological products used in allergen-specific immunotherapy. Furthermore, it compares the advantages and disadvantages of different immunological products and their respective mechanisms of action. …”
Get full text
Article -
1557
Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway
Published 2020-01-01“…Combination of antiangiogenesis and immunotherapy may be an effective strategy for treatment of solid tumors. …”
Get full text
Article -
1558
DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer’s disease
Published 2025-01-01“…While newly approved amyloid immunotherapy has been reported, effective AD drugs remain to be identified. …”
Get full text
Article -
1559
Investigation of Scutellaria Barbata’s immunological mechanism against thyroid cancer using network pharmacology and experimental validation
Published 2025-01-01“…This study combines database predictions with experimental validation to reveal the potential mechanisms of SBH against TC, providing effective strategies for the immunotherapy of TC.…”
Get full text
Article -
1560
Transcriptome profiling revealed multiple circadian rhythm-related genes associated with common gynecological cancers
Published 2025-01-01“…It is notable that multiple immune-related signaling pathways were associated with the clinical risk of CC, and the immunotherapy sensitivity was worse in the high-risk group. …”
Get full text
Article